Endophthalmitis after intravitreal injections

John B. Miller; Luis Haddock; Joan W. Miller

doi:10.1007/978-3-319-29231-1_7

Endophthalmitis after intravitreal injections

John B. Miller, Luis Haddock, Joan W. Miller

Ophthalmology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Endophthalmitis after intravitreal injections is a rare but devastating complication of this common eye procedure. Patients typically present within 5 days of their injection with decreased vision, pain, and redness. However, the absence of any one of these in the presence of other symptoms should not exclude the diagnosis of endophthalmitis. Treatment consists of obtaining a vitreous sample and administering intravitreal antibiotics. Vitrectomy may be indicated in some cases. Preventive measures include the use of a lid speculum and topical povidone-iodine during the procedure, and clinicians may consider the use of masks or having all participants refrain from speaking.

Original language	English (US)
Title of host publication	Endophthalmitis
Publisher	Springer International Publishing
Pages	131-137
Number of pages	7
ISBN (Electronic)	9783319292311
ISBN (Print)	9783319292298
DOIs	https://doi.org/10.1007/978-3-319-29231-1_7
State	Published - Jan 1 2016

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-319-29231-1_7

Fingerprint Dive into the research topics of 'Endophthalmitis after intravitreal injections'. Together they form a unique fingerprint.

Cite this

@inbook{d6b8f021f6a04a1d961d9e3797b82115,

title = "Endophthalmitis after intravitreal injections",

abstract = "Endophthalmitis after intravitreal injections is a rare but devastating complication of this common eye procedure. Patients typically present within 5 days of their injection with decreased vision, pain, and redness. However, the absence of any one of these in the presence of other symptoms should not exclude the diagnosis of endophthalmitis. Treatment consists of obtaining a vitreous sample and administering intravitreal antibiotics. Vitrectomy may be indicated in some cases. Preventive measures include the use of a lid speculum and topical povidone-iodine during the procedure, and clinicians may consider the use of masks or having all participants refrain from speaking.",

author = "Miller, {John B.} and Luis Haddock and Miller, {Joan W.}",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/978-3-319-29231-1_7",

language = "English (US)",

isbn = "9783319292298",

pages = "131--137",

booktitle = "Endophthalmitis",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Endophthalmitis after intravitreal injections

AU - Miller, John B.

AU - Haddock, Luis

AU - Miller, Joan W.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Endophthalmitis after intravitreal injections is a rare but devastating complication of this common eye procedure. Patients typically present within 5 days of their injection with decreased vision, pain, and redness. However, the absence of any one of these in the presence of other symptoms should not exclude the diagnosis of endophthalmitis. Treatment consists of obtaining a vitreous sample and administering intravitreal antibiotics. Vitrectomy may be indicated in some cases. Preventive measures include the use of a lid speculum and topical povidone-iodine during the procedure, and clinicians may consider the use of masks or having all participants refrain from speaking.

AB - Endophthalmitis after intravitreal injections is a rare but devastating complication of this common eye procedure. Patients typically present within 5 days of their injection with decreased vision, pain, and redness. However, the absence of any one of these in the presence of other symptoms should not exclude the diagnosis of endophthalmitis. Treatment consists of obtaining a vitreous sample and administering intravitreal antibiotics. Vitrectomy may be indicated in some cases. Preventive measures include the use of a lid speculum and topical povidone-iodine during the procedure, and clinicians may consider the use of masks or having all participants refrain from speaking.

UR - http://www.scopus.com/inward/record.url?scp=84978285341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978285341&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-29231-1_7

DO - 10.1007/978-3-319-29231-1_7

M3 - Chapter

AN - SCOPUS:84978285341

SN - 9783319292298

SP - 131

EP - 137

BT - Endophthalmitis

PB - Springer International Publishing

ER -